aclacinomycin has been researched along with Leukemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobichon, H; Gillet, R; Trentesaux, C | 1 |
| Meng, XL | 1 |
| Kawamura, S; Maekawa, I; Miyake, T; Sasaki, H | 1 |
| Gahrton, G | 1 |
| Bayssas, M; de Vassal, F; Delgado, M; Gil, MA; Gouveia, J; Hayat, M; Jasmin, C; Machover, D; Mathé, G; Misset, JL; Ribaud, P; Schwarzenberg, L | 1 |
| Broglio, C; Carpentier, Y; Desplaces, A; Dufer, J; Joly, P | 1 |
| Kim, HS; Kim, YH; Lee, JJ; Yoo, OJ | 1 |
| Colige, A; Devy, L; Foidart, JM; Garnotel, R; Hollender, P; Jeannesson, P; Munaut, C; Noël, A | 1 |
| Ishikawa, I; Kaneko, H; Katoh, M; Kojima, N; Shirai, T; Umeda, M; Yamaguchi, R; Yamauchi, M | 1 |
| Krc, I; Mlcochová, E; Myslivecek, M | 1 |
| Hibi, S; Imashuku, S; Morimoto, S; Morioka, Y; Nakajima, T; Sugimoto, T; Todo, S | 1 |
| Masaoka, T | 1 |
1 review(s) available for aclacinomycin and Leukemia
| Article | Year |
|---|---|
Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Age Factors; Aminoacridines; Amsacrine; Anthraquinones; Antibodies, Monoclonal; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Infant; Interferons; Leukemia; Leukemia, Lymphoid; Liposomes; Middle Aged; Mitoxantrone; Naphthacenes; Prognosis; Teniposide; Transplantation, Homologous; Transplantation, Isogeneic; Vinblastine; Vindesine | 1983 |
11 other study(ies) available for aclacinomycin and Leukemia
| Article | Year |
|---|---|
Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation.
Topics: Aclarubicin; Adjuvants, Immunologic; Antibody Specificity; Cell Compartmentation; Cell Nucleus; Cell Transformation, Neoplastic; DNA-Binding Proteins; Dose-Response Relationship, Drug; Erythrocytes; Erythroid Precursor Cells; Erythroid-Specific DNA-Binding Factors; Erythropoiesis; GATA1 Transcription Factor; Gene Expression Regulation, Leukemic; Hemoglobins; Humans; K562 Cells; Leukemia; Microscopy, Confocal; Phosphoric Monoester Hydrolases; Phosphorylation; Transcription Factors | 2002 |
[Sensitivity of survivin-positive primary leukemia cells to chemotherapy].
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Antineoplastic Agents; Cell Survival; Cytarabine; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Leukemia; Male; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Tumor Cells, Cultured | 2005 |
[Comparative evaluation of combined chemotherapeutic regimens in acute non-lymphocytic leukemia].
Topics: Aclarubicin; Acute Disease; Adult; Age Factors; Ancitabine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone | 1983 |
Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Child; Drug Evaluation; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Naphthacenes | 1980 |
Quantitative morphological assessment of erythroblastic differentiation induced, in vitro, in human K562 leukemic cells.
Topics: Aclarubicin; Alkaloids; Benzophenanthridines; Cell Differentiation; Erythroblasts; Hemin; Hemoglobins; Humans; Leukemia; Phenanthridines; Tumor Cells, Cultured | 1993 |
Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
Topics: Aclarubicin; Adjuvants, Immunologic; Antibiotics, Antineoplastic; Cell Division; Culture Media; Humans; Leukemia; Magnetic Resonance Spectroscopy; Melanoma; Streptomyces; Tumor Cells, Cultured | 1996 |
Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid.
Topics: Aclarubicin; Antineoplastic Agents; Cell Differentiation; Cell Movement; HL-60 Cells; Humans; Leukemia; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phenylalanine; Serine Endopeptidases; Thiophenes; Tissue Inhibitor of Metalloproteinases; Tretinoin; Tumor Cells, Cultured | 2002 |
[The effect of antileukemic drugs on superoxide (O2-) production by human neutrophils].
Topics: Aclarubicin; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Naphthacenes; Neutrophils; Superoxides | 1987 |
Combination therapy with aclacinomycin in acute leukemia.
Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia; Naphthacenes; Thioguanine | 1986 |
[Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia; Methotrexate; Naphthacenes; Vincristine | 1987 |
[Present status of the multidisciplinary treatment of acute leukemia].
Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Doxorubicin; Humans; Leukemia; Naphthacenes; Vincristine; Vindesine | 1985 |